↓ Skip to main content

Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Overview of attention for article published in this source, September 2014
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
8 X users
wikipedia
2 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
150 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Published by
John Wiley & Sons, Ltd, September 2014
DOI 10.1002/14651858.cd005041.pub2
Pubmed ID
Authors

Epstein, Tamir, Patsopoulos, Nikolaos A, Weiser, Mark

Abstract

Symptoms of attention deficit hyperactivity disorder (ADHD), diagnosed mainly in children, often persist into adulthood. Adults in this group have a high rate of other psychiatric problems and functional difficulties in a number of key areas such as academic achievement, interpersonal relationships, and employment. Although the usefulness of immediate-release methylphenidate in children has been extensively studied, studies in adults, which are few, demonstrate varying results.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 150 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 17%
Student > Bachelor 21 14%
Researcher 19 13%
Student > Ph. D. Student 16 11%
Student > Doctoral Student 14 9%
Other 26 17%
Unknown 29 19%
Readers by discipline Count As %
Medicine and Dentistry 46 31%
Psychology 25 17%
Neuroscience 9 6%
Social Sciences 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Other 22 15%
Unknown 34 23%